LAST UPDATED ON 5/27/2021
If your child is 12 or older, they may be eligible for the Pfizer-BioNTech vaccine. Please click here to view COVID-19 vaccination information for MS patients and patients treated with medications.
As of 3/16/21, Moderna launched a phase 2/3 clinical trial on the Covid vaccine in children 6 months to 11 years old, after launching its trial in 12 to 17 year old children last year. Johnson & Johnson is planning to begin their trial in children 12 to 17 years old in the near future, before moving down to younger age groups. Pfizer recently completed a clinical trial in children 12 to 15 years old, in which their vaccine showed 100% efficacy against COVID-19. As of 5/10/21, the FDA has authorized the Pfizer-BioNTech vaccine for this age group. We will update this page frequently as more information is available.
Guidance on COVID-19 vaccines for youth with MS from the National MS Society
Youth aged 12-17 should be vaccinated against COVID-19
Children and adolescents are at risk of severe illness from COVID-19
Youth with MS should be vaccinated against COVID-19
Family members of youth with MS should be vaccinated against COVID-19
The COVID-19 vaccines are not expected to cause MS or trigger an MS relapse
There is no evidence that the vaccines will affect fertility
Individuals consulted in the development of this guidance
The link to preregister for a vaccine appointment can be found here and the link to find an appointment location can be found here.
Guía sobre las vacunas COVID-19 para jóvenes con MS de la Sociedad Nacional de Esclerosis Múltiple
Los jóvenes de 12-17 años deben vacunarse contra el COVID-19
Los niños y adolescentes corren peligro de enfermarse gravemente con el COVID-19
Los jóvenes con esclerosis múltiple deben vacunarse contra el COVID-19
Los familiares de jóvenes con esclerosis múltiple deben vacunarse contra el COVID-19
No se tiene previsto que las vacunas contra el COVID-19 causen esclerosis múltiple ni produzcan una recaída
No hay evidencia de que las vacunas afectan la fertilidad
La Sociedad Nacional de Esclerosis Múltiple consultó con las siguientes personas para emitir esta recomendación
El sitio web para preinscribirse para una cita de vacuna se puede encontrar aquí y el sitio web para encontrar un lugar para la cita se puede encontrar aquí.